e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
Zabini Diana, Heinemann Akos, Foris Vasile, Nagaraj Chandran, Nierlich Patrick, Bálint Zoltán, Kwapiszewska Grazyna, Lang Irene M., Klepetko Walter, Olschewski Horst, Olschewski Andrea
Source:
Eur Respir J 2014; 44: 951-962
Journal Issue:
October
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zabini Diana, Heinemann Akos, Foris Vasile, Nagaraj Chandran, Nierlich Patrick, Bálint Zoltán, Kwapiszewska Grazyna, Lang Irene M., Klepetko Walter, Olschewski Horst, Olschewski Andrea. Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J 2014; 44: 951-962
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018
Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Correlation between endothelial haemostatic markers in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Year: 2007
Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 272-282
Year: 2015
Platelet function in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Year: 2009
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021
Relationship between endothelial haemostatic markers in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Diagnosis of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2017; 26: 160108
Year: 2017
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018
Year: 2018
Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Systemic inflammation and pulmonary hypertension in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept